Indian pharmaceutical giant Sun Pharma is set to acquire US-based Organon & Co. for $11.75 billion in an all-cash deal. This landmark acquisition, one of India’s largest overseas ventures, will propel Sun Pharma into the top 25 global pharma companies. The move significantly bolsters its presence in women’s health and biosimilars, expanding its global reach
Global oil prices surged Monday, with Brent crude hitting $107.49 and WTI reaching $96.17, driven by stalled US-Iran peace talks and ongoing Strait of Hormuz disruptions. This supply squeeze, exacerbated by restricted shipping, has led Goldman Sachs to revise its Q4 oil price forecasts upwards, signaling continued market volatility.
Stock market recommendations: For the trading week starting April 27, 2026, Tata Steel, and Cyient DLM are the top stock picks from Motilal Oswal Wealth Management Research Desk.
Indian summer vacation plans to exotic locales are facing a significant setback. A combination of the West Asia conflict and a depreciating rupee has inflated overseas tour package costs by approximately 20%. This surge, coupled with geopolitical instability, has led to a sharp decline in international travel demand, particularly to the Gulf and Europe, impacting
Amidst global supply chain disruptions, India’s economic leaders are prioritizing domestic strength. Finance Minister Nirmala Sitharaman highlighted the vast Indian consumer base as a key defense, while industry titans emphasised strategic self-reliance in manufacturing and a pivot to green energy. This approach aims to leverage India’s demographic dividend and workforce to navigate international volatility and
